
£64.6 million AIM IPO for Trellus Health


About Trellus Health
Trellus Health is commercialising the provision of digital chronic condition management solutions for health plans and employers that utilise the scientifically validated Gaining Resilience Through Transitions (GRITT™) methodology and a proprietary HIPAA compliant technology platform called TrellusElevate™, to coordinate and deliver personalised care remotely via telemedicine.

The GRITT™ methodology and resilience-driven multidisciplinary care model have been scientifically validated to demonstrate meaningful improvements in patient outcomes and over 85% reduction in emergency department visits and hospitalisations. The Company is initially focused on Inflammatory Bowel Diseases (“IBD”), which include the chronic incurable conditions of Crohn’s Disease and ulcerative colitis, but also considers its approach to have potential utility and demand across many chronic conditions.
Key facts
Contact us
Call (+44) 020 7496 3000
or email enquiries@singercm.com